SPOTLIGHT: Zyrtec-D gets cleared for OTC sale


Prescription Zyrtec-D is dead! Long live Zyrtec-D! The FDA will allow Johnson & Johnson--which owns over-the-counter rights to the allergy med--to sell Zyrtec-D without a prescription, a move that will undoubtedly cut into Pfizer's sales of the prescription form. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.